[Remote] Clinical Trial Associate at Bristol-Myers Squibb

United States

Apply Now

Not SpecifiedCompensation

N/AExperience Level

N/AJob Type

Not SpecifiedVisa

N/AIndustries

Requirements

Minimum 1-2 years clinical trial experience
Bachelor’s degree required. Life sciences or related field is preferred
Independent professional who proactively communicates frequently and effectively
Organized and able to work on multiple projects with tight deadlines
High energy level; positive attitude; works well under stress; assertive and effective communicator
Hands-on, action-oriented, and able to implement effectively

Responsibilities

Work closely with the study execution team to provide project system, tracking and administrative support in executing all of RayzeBio clinical studies from study start-up, conduct and close-out phases
Maintain and manage the study Trial Master File (TMF) in compliance with ICH-GCP and company SOPs
Maintain study team SharePoint sites, study trackers and other databases, which may include data entry and filing of electronic documents
Track and manage study and site essential documents
Support vendor and site contract tracking and maintain contracts in applicable RayzeBio systems
Organize and manage the study execution team meetings, including meeting coordination, agenda preparation and minutes
Communicate effectively with all internal and external stakeholders in a positive and professional manner
Participate in internal audits and inspection readiness activities
Participate in teleconference calls and meetings as requested

Skills

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free